Fruquintinib combination therapy improves quality-adjusted survival in metastatic colorectal cancer
3D illustration of the colon – Stock.adobe.com The combination of fruquintinib (Fruzakura) and optimal supportive care led to Results from an in-phase post-hoc analysis show that quality-adjusted time to absence of symptoms of disease or toxicity increased when compared with placebo and optimal supportive care in previously treated patients with metastatic colorectal cancer (CRC). The […]
Fecal microbiota transplant increases survival in metastatic colorectal cancer treatment
In a recent study published in e-clinical medicineresearchers are evaluating the use of fecal microbiota transplantation to increase the efficacy of anti-programmed cell death protein 1 (PD-1) therapy for patients with microsatellite-stable metastatic colorectal cancer. study: Fecal microbiota transplantation with tislelizumab and fruquintinib in refractory microsatellite-stable metastatic colorectal cancer: an open-label, single-arm, phase II study […]
Sponsored: Colorectal screening is the key to early detection and survival of colon cancer
Incidence is decreasing in adults over 65 years of age, but increasing in younger adults. But colorectal exams can save lives. Colorectal cancer is the third leading cause of cancer death in the United States, excluding certain types of skin cancer. Incidence rates are decreasing among adults 65 years and older; rising In young adults. […]
Individualized survival planning for colon cancer patients receiving adjuvant chemotherapy
Healthcare providers caring for colon cancer survivors need personalized survival plans for patients that monitor for cancer recurrence while also managing other long-term effects, according to a review published in It is necessary to formulate a clinical colorectal cancer.1 Although colon cancer remains one of the most commonly diagnosed cancers in the United States, the […]
New treatment option for metastatic colorectal cancer extends survival | VUMC Reporter
Written by Tom Wilemon A new treatment is on the horizon for patients with metastatic colorectal cancer who have run out of treatment options. Results of international clinical trials, Posted on June 15th lancetshowed that fruquintinib, a selective targeted therapy, resulted in statistically significant improvements in overall survival and progression-free survival. Median survival for patients […]